Myriad Genetics Inc (MYGN): Shareholders' Equity
$368.00M
As of 2025-12-31
$303.90M
As of 2026-06-30
-25.4%
3-year compound annual growth
-16.0%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $368.00M | -47.5% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $701.10M | -10.5% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $783.20M | -11.6% | 2026-02-24, Balance as of period end |
| 2022-12-31 | $885.80M | -8.5% | 2025-02-28, Balance as of period end |
| 2021-12-31 | $967.80M | +9.9% | 2024-02-28, Balance as of period end |
| 2020-12-31 | $881.00M | n/a | 2022-02-25, Balance as of period end |
| 2020-06-30 | $918.20M | -15.7% | 2020-08-13, Balance as of period end |
| 2019-06-30 | $1.09B | +12.7% | 2020-08-13, Balance as of period end |
| 2018-06-30 | $966.10M | +25.7% | 2019-08-13, Balance as of period end |
| 2017-06-30 | $768.40M | +3.9% | 2018-08-24, Balance as of period end |
| 2016-06-30 | $739.60M | +11.8% | 2018-08-24, Balance as of period end |
| 2015-06-30 | $661.70M | -8.0% | 2018-08-24, Balance as of period end |
| 2014-06-30 | $719.00M | -1.3% | 2016-08-10, Balance as of period end |
| 2013-06-30 | $728.60M | +14.6% | 2015-08-12, Balance as of period end |
| 2012-06-30 | $635.66M | +12.2% | 2014-08-13, Balance as of period end |
| 2011-06-30 | $566.79M | +1.7% | 2013-08-14, Balance as of period end |
| 2010-06-30 | $557.58M | +28.4% | 2012-08-15, Balance as of period end |
| 2009-06-30 | $434.22M | n/a | 2011-08-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $368.00M | -47.5% |
| Neogen Corp (NEOG) | 2026-05-31 | $2.09B | +1.0% |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $1.09B | +0.2% |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $1.92B | -35.7% |
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $1.61B | +0.6% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $671.39M | -23.0% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $68.78M | -16.5% |
| Immucell Corp (ICCC) | 2025-12-31 | $27.06M | -1.7% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$6.93M | n/m |
Compare MYGN, NEOG, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗